Essential Medicines Strategic Stockpile Act of 2023
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 20, 2023)
Essential Medicines Strategic Stockpile Act of 2023
This bill requires the Department of Health and Human Services (HHS) to create a pilot program to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.
To carry out the pilot program, HHS must enter into contracts for a term of up to three years with drug manufacturers, co-op or chain pharmacy warehouses, or other eligible entities to create a six-month stockpile of up to 50 types of such drugs.
The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
What just happenedJan 27, 2023
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJan 20, 2023
- Jan 27, 2023Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 20, 2023IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 20, 2023IntroReferralIntro-H
Introduced in House
- Jan 20, 2023IntroReferral1000
Introduced in House